Residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer

Bookmark and Share
Published: 19 Dec 2019
Views: 155
Rating:
Save
Prof William Symmans - MD Anderson Cancer Center, Houston, Texas

Prof William Symmans gives a press conference at the 2019 San Antonio Breast Cancer Symposium about the results of a multi-centre pooled analysis on residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer.

Watch our interview with Prof Symmans here.

Read more about the study here